Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
 

Fearing uncontrolled mergers and acquisitions by foreign drug firms that could lead to further increase in drug prices and also cartelisation, the government is eyeing capping the 100 per cent foreign direct investment (FDI) currently allowed through automatic route in the pharma sector at 49 per cent and that too through the government route.

 
 
India becomes a hot market for optional vaccines.
Two years after it slammed into a US regulatory wall, Ranbaxy Laboratories, under its Japanese owners, is working the hard way to be back among the stars.
US reforms are likely to bring business to health care, insurance BPO firms.
 
 
Multinationals are closing in on Big Pharma, but there are enough mid-size stars as well.
Advertisement